Renzo Marcolongo, Stefania Rizzo, Alessia Cerutti, Elena Reffo, Biagio Castaldi, Anna Baritussio, Cristina Basso, Giovanni Di Salvo, Alida L P Caforio
The role of immunosuppressive therapy (IT) in paediatric autoimmune/immune-mediated myocarditis remains poorly defined. To explore its role, we present a series of three consecutive paediatric patients with biopsy-proven, virus negative, autoimmune/immune-mediated myocarditis, with distinct clinical and pathological features, who have been successfully treated with IT, a 14-year-old boy with Loeffler's fibroblastic parietal endomyocarditis, a 6-year-old child with celiac disease with chronic active lymphocytic myocarditis, and a 13-year-old boy with long-standing heart failure and active lymphocytic myocarditis...
January 16, 2021: ESC Heart Failure